Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Peiró

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Revista Clinica Espanola|April 10, 2012
[Bioethics limitation of therapeutic effort in pediatrics]A M Peiró Peiró, A Ausina Gómez, M Tasso Cereceda
Sleep Medicine Reviews|August 8, 2020
Sleep in autism: A biomolecular approach to aetiology and treatmentP Ballester, A L Richdale, E K Baker, et al.
Pharmacological Research|March 23, 2011
Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activationA M Peiró, L Climent, P Zapater, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 1, 2008
Efficacy and tolerance of metamizole versus morphine for acute pancreatitis painA M Peiró, J Martínez, E Martínez, et al.
Pharmacological Research|November 11, 2008
Pharmacogenetic relevance of the CYP2C9*3 allele in a tenoxicam bioequivalence study performed on SpaniardsA M Peiró, J Novalbos, P Zapater, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
Use of CYP2D6 substrates and inhibitors during pain management with analgesic opioids: Drug-drug interactions that lead to lack of analgesic effectivenessJ Muriel, M Escorial, C Carratalá, et al.
Psychopharmacology|November 13, 2012
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apartA M Peiró, M Farré, P N Roset, et al.
Psychopharmacology|April 9, 2004
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokineticsM Farré, R de la Torre, B O Mathúna, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2010
The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reportsL Llanos, R Moreu, T Ortin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Revista Clinica Espanola|April 10, 2012
[Bioethics limitation of therapeutic effort in pediatrics]A M Peiró Peiró, A Ausina Gómez, M Tasso Cereceda
Sleep Medicine Reviews|August 8, 2020
Sleep in autism: A biomolecular approach to aetiology and treatmentP Ballester, A L Richdale, E K Baker, et al.
Pharmacological Research|March 23, 2011
Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activationA M Peiró, L Climent, P Zapater, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 1, 2008
Efficacy and tolerance of metamizole versus morphine for acute pancreatitis painA M Peiró, J Martínez, E Martínez, et al.
Pharmacological Research|November 11, 2008
Pharmacogenetic relevance of the CYP2C9*3 allele in a tenoxicam bioequivalence study performed on SpaniardsA M Peiró, J Novalbos, P Zapater, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
Use of CYP2D6 substrates and inhibitors during pain management with analgesic opioids: Drug-drug interactions that lead to lack of analgesic effectivenessJ Muriel, M Escorial, C Carratalá, et al.
Psychopharmacology|November 13, 2012
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apartA M Peiró, M Farré, P N Roset, et al.
Psychopharmacology|April 9, 2004
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokineticsM Farré, R de la Torre, B O Mathúna, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2010
The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reportsL Llanos, R Moreu, T Ortin, et al.
Pageof 1